One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress-Reference-Cited by-同舟云学术

One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress

Published:2010-09 Issue:1 Volume:212 Page:223-229
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Bunck Mathijs C.,Cornér Anja,Eliasson Bjorn,Heine Robert J.,Shaginian Rimma M.,Wu Yan,Yan Ping,Smith Ulf,Yki-Järvinen Hannele,Diamant Michaela,Taskinen Marja-Riitta

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes;Tushuizen;Postgrad Med J,2005

2. Diabetic dyslipidaemia: from basic research to clinical practice;Taskinen;Diabetologia,2003

3. Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis;De Man;Eur J Clin Investig,1996

4. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism;Ginsberg;Circulation,2002

5. Postprandial hyperglycemia and diabetes complications: is it time to treat?;Ceriello;Diabetes,2005

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

2. Incretin and glucagon receptor polypharmacology in chronic kidney disease;American Journal of Physiology-Endocrinology and Metabolism;2024-06-01

3. GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage;American Journal of Physiology-Heart and Circulatory Physiology;2024-05-01

4. Impaired Fibroblast Growth Factor 21 (FGF21) Associated with Visceral Adiposity Leads to Insulin Resistance: The Core Defect in Diabetes Mellitus;Current Diabetes Reviews;2024-04-26

5. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress;Free Radical Biology and Medicine;2024-03